Your browser doesn't support javascript.
loading
Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane.
Pang, Hailin; Ouyang, Jiayue; Yang, Zengwen; Shang, Hong; Liang, Guoxin.
Afiliação
  • Pang H; Key Laboratory of Acquired Immune Deficiency Syndrome (AIDS) Immunology of Ministry of Health, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang 110122, China.
  • Ouyang J; National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang 110122, China.
  • Yang Z; Key Laboratory of Acquired Immune Deficiency Syndrome (AIDS) Immunology of Ministry of Health, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang 110122, China.
  • Shang H; National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang 110122, China.
  • Liang G; Key Laboratory of Acquired Immune Deficiency Syndrome (AIDS) Immunology of Ministry of Health, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang 110122, China.
Proc Natl Acad Sci U S A ; 120(3): e2212991120, 2023 01 17.
Article em En | MEDLINE | ID: mdl-36638209
ABSTRACT
The urokinase-type plasminogen activator (uPA) system consists of the proteinase uPA, its receptor (PLAUR/uPAR). Under physiological conditions, uPA and PLAUR are predominantly expressed by blood cells, including neutrophils, monocytes, and macrophages, and play important roles in cell activation, adhesion, migration, and extravasation. Here, we report that PLAUR, which is highly expressed in macrophages and dendritic cells (DCs) but hardly expressed in CD4+ T cells, inhibits the release of HIV-1 progeny virions from the cell membrane. Silencing PLAUR markedly enhanced the transmission of HIV-1 in macrophages and DCs. We further demonstrated that PLAUR is localized at the cell membrane to block the release of HIV-1 virions. Interestingly, we found that uPA compromises the PLAUR-mediated inhibition to slightly enhance HIV-1 production in primary macrophages and DCs. In the absence of PLAUR, this enhanced effect induced by uPA is abrogated. In conclusion, PLAUR is a new anti-HIV-1 protein produced in both macrophages and DCs where it inhibits HIV-1 transmission. This discovery may provide a novel therapeutic target for combating HIV.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Replicação Viral / HIV-1 / Receptores de Ativador de Plasminogênio Tipo Uroquinase Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Replicação Viral / HIV-1 / Receptores de Ativador de Plasminogênio Tipo Uroquinase Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article